SUTENT

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug SUTENT contains one active pharmaceutical ingredient (API):

1 Sunitinib
UNII LVX8N1UT73 - SUNITINIB MALATE

Sunitinib inhibits multiple RTKs that are implicated in tumour growth, neoangiogenesis, and metastatic progression of cancer.

Read about Sunitinib

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SUTENT Hard capsule European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01EX01 Sunitinib L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EX Other protein kinase inhibitors
Discover more medicines within L01EX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10004M, 10009T, 10010W, 10459L, 10464R, 10473F, 10503T, 10504W, 11250D, 11253G, 11256K, 11266Y, 2837H, 2842N, 2959R, 9417P, 9418Q, 9419R, 9420T, 9421W, 9422X, 9488J, 9489K, 9490L
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 522720050087617, 522720050087717, 522720050087817
Country: CA Health Products and Food Branch Identifier(s): 02280795, 02280809, 02280817
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 27.733-06-07, 27.734-1-03-12, 27.738-06-07
Country: EE Ravimiamet Identifier(s): 1257982, 1257993, 1258006, 1353282, 1353293, 1353305, 1426632, 1426643
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 06347001, 06347002, 06347003
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 099863, 099872, 099881
Country: FR Base de données publique des médicaments Identifier(s): 63841059, 65283820, 69225978
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 136358, 136363, 136365
Country: HK Department of Health Drug Office Identifier(s): 55404, 55405, 55406, 59785
Country: IE Health Products Regulatory Authority Identifier(s): 88684, 88685, 88686
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6045, 6046, 6047
Country: JP 医薬品医療機器総合機構 Identifier(s): 4291018M1029
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1030588, 1030589, 1030590, 1030591, 1030592, 1030593, 1038372, 1038373, 1060892, 1061423
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 233M2006
Country: NL Z-Index G-Standaard, PRK Identifier(s): 83453, 83461, 83488
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 12700, 12701, 12702, 17938
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100114829, 100116923, 100118520, 100214933
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65026001, W65027001, W65028001
Country: SG Health Sciences Authority Identifier(s): 13254P, 13255P, 13256P, 13920P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 8013061H, 8013062H, 8013063H
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8681308157553, 8681308158994, 8681308159427, 8681308159434, 8681308159571
Country: US FDA, National Drug Code Identifier(s): 0069-0550, 0069-0770, 0069-0830, 0069-0980
Country: ZA Health Products Regulatory Authority Identifier(s): 41/26/0195, 41/26/0196

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.